Article
19 Jan 2024
Why Citramon Should Not Become A Xerox Or Pampers
AUTHORS CONTENT
Article
19 Jan 2024
Roaches In Your Business: Five Steps To Protect Intellectual Property
Article
19 Jan 2024
Non-Transparent Copyright Levies Slow Down Industry Development
Article
15 Jan 2024
Adaptation Period
Article
12 Jan 2024
Legal Expert: Corvalol Recognized As A Medication, Not A Trademark
Article
12 Jan 2024
Machinery Rights
Article
12 Jan 2024
IP-Weapon
Article
12 Jan 2024
The Name "Corvalol" Is Not Associated With A Specific Manufacturer
Article
22 Dec 2023
Ukraine's Aspirations For Intellectual Property Protection: What You Should Know
Article
22 Dec 2023
The 'Inside-Out' Approach To Fair Justice In Ukraine. Oleksandr Mamunya Opinion
Article
21 Jul 2023
Patent Invalidation Matter
Article
19 Jul 2023
Exciting Victory In The Supreme Court
Article
21 Apr 2023
The Impact Of Patent Expiration On Drug Prices And Availability
Article
23 Mar 2023
New Promotion